The article evaluates Pfizer Inc. in comparison to other dividend-paying stocks under $50. Despite recent market downturns, analysts remain positive on equity investments, highlighting the potential of dividend stocks for long-term returns. Pfizer's consistent dividend history and increased payouts make it a favorable choice for investors seeking stable income.